Grifols Achieves Results From Phase 4 Study Of Fanhdi In Patients With Von Willebrand Disease
Benzinga Newsdesk 2 years ago
BiotechNewsGeneral
https://www.grifols.com/en/view-news/-/news/grifols-achieves-positive-results-from-phase-4-study-of-fanhdi-double-inactivated-human-anti-hemophilic-factor-in-patients-with-von-willebrand-disease